What's coming to Contemporary OB/GYN this week?
The rate of unintended pregnancies throughout the US military declined significantly since 2005, according to a study published in Contraception.1 Nevertheless, authors say, the burden that such pregnancies place on female servicemembers and the military health care system continues to demand aggressive upfront education and counseling.
After the Antenatal Late Preterm Steroid (ALPS) trial showed a decrease in respiratory complications following steroid administration, steroid exposure among newborns increased.
While access to prenatal care did increase in states after Medicaid expansion, disparities persisted and even increased among Asian and Hispanic immigrant pregnant women, according to an analysis in JAMA Network Open.
Low-molecular-weight heparin (LMWH) did not increase the live-birth rate in comparison to standard therapy for pregnant women.
Research suggests that combined hormonal contraceptives (CHC) have a similar safety profile to progestin-only contraceptives (POC) with regard to women with sickle cell disease and their risk of thromboembolism (TE).
Adaptability and flexibility will be needed to deal with for challenges next year.
This month, the US Centers for Medicare & Medicaid Services (CMS) announced the draft rule with five key provisions and five requests for information. If implement, CMS estimated the changes would save physicians and hospitals more than $15 billion over 10 years.
Check back soon for additional updates!
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More